Effect of 3q oncogenes SEC62 and SOX2 on lymphatic metastasis and clinical outcome of head and neck squamous cell carcinomas

By F. Bochen, Hana Adisurya, S. Wemmert, C. Lerner, Markus Greiner, R. Zimmermann, A. Hasenfus, M. Wagner, S. Smola, T. Pfuhl and 4 more. 2016

Subfields: Cancer Research, Oncology, Otorhinolaryngology

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. M. Knebel
2. Maximilian Linxweiler
3. S. Körner
4. L. Brust
5. Matthias Schneider
6. F. Braun
7. S. Wemmert
8. J. Kühn

Citations in the corpus

• Expression of 3q Oncogene SEC62 Predicts Survival in Head and Neck Squamous Cell Carcinoma Patients Treated with Primary Chemoradiation (2023, background): “Nonetheless, SEC62 expression showed a very homogeneous expression pattern within tumors in previous studies of our group, including also HNSCC samples [22,41].”